Short answer
Oscar Health, Inc. (OSCR) filed an 8-K current report with the SEC on August 6, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Oscar Health announced financial results for the quarter ended June 30, 2026.
Oscar Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Oscar Health announced financial results for the quarter ended June 30, 2026
- Results press release furnished as Exhibit 99.1, providing the detailed financial figures for investor review
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $4.88B, up from $2.86B, with membership reaching 2.96M from 2.02M
- MLR improved to 79.2% from 91.1%, including $164M favorable prior-period reserve development
- Q2 operating earnings $388.6M versus a $230.5M loss, with net income $361.8M and diluted EPS $1.10
- Updated 2026 operating earnings outlook $500M-$700M, raised from $250M-$450M
- Updated 2026 MLR outlook 81.5%-82.5%, while revenue outlook remains $18.7B-$19.0B
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Oscar Health, Inc. 8-K filings
Get the next OSCR 8-K as it lands
Follow OSCR for push alerts, or ask the research agent what this filing means.